Lorus Therapeutics Inc.

Cancer-focused biopharma company announces corporate changes

Published in Law and Health Weekly, December 17th, 2005

Lorus Therapeutics Inc., a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products and technologies for the management of cancer, announced the departure of three senior managers as part of a reorganization of the company.

Leaving are Shane Ellis, vice president, legal affairs and corporate secretary; Bruce Rowlands, senior vice president of planning and public affairs; and Paul Van Damme, chief financial officer.

These changes are in addition to those announced on November 2, 2005, when the company reduced its staff by approximately 35%. Paul Van Damme's responsibilities will be assumed by Elizabeth...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-12-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry